Últimos ensayos


EudraCT Number: 2006-004007-19 Sponsor Protocol Number: AV-007-IM Start Date: 2006-11-16
Sponsor Name: Nycomed Austria GmbH
Full Title: A multi-centre, double-blind, placebo-controlled, randomised, parallel group clinical trial to evaluate efficacy and safety of Actovegin® in diabetic type 2 patients with symptomatic diabetic perip...
Medical condition: Diabetic Polyneuropathy
Disease: Version SOC Term Classification Code Term Level
8.1 10012685 Diabetic polyneuropathy LLT
Population Age: Adults Gender: Male, Female
Trial protocol: AT (Prematurely Ended)
Trial results: View results

EudraCT Number: 2006-005291-41 Sponsor Protocol Number: BIOC/AMBV/906 Start Date: 2006-11-16
Sponsor Name: CYATHUS Exquirere PharmaforschungsGmbH
Full Title: A single center, open, pilot study to evaluate the pharmacokinetic profile of a new galenic formulation of an Ambroxol-Hydrochloride (Ambroxol-HCl) spray: Ambroxol “CYATHUS” 50 mg/mL Oral Spray, ad...
Medical condition:
Disease: Version SOC Term Classification Code Term Level
8.1 10006440 Bronchial obstruction LLT
Population Age: Adults Gender: Male
Trial protocol: AT (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2006-001657-94 Sponsor Protocol Number: SPCG 13 Start Date: 2006-11-16
Sponsor Name: [...] 1. 2. Scandinavian Prostate Cancer Group/ P.O. Hedlund
Full Title: Randomized adjuvant phase III trial of six cycles of docetaxel+hormonal treatment versus hormonal treatment in patients with intermediate or high-risk prostate cancer treated with radical radiothe...
Medical condition: Intermediate or high-risk prostate cancer treated with radical radiotherapy
Disease: Version SOC Term Classification Code Term Level
8.1 10060862 Prostate cancer PT
Population Age: Adults, Elderly Gender: Male
Trial protocol: FI (Ongoing) IE (Completed) SE (Ongoing)
Trial results: (No results available)

EudraCT Number: 2006-004565-33 Sponsor Protocol Number: EASI Start Date: 2006-11-16
Sponsor Name: Chemische Fabrik Kreussler & Co.GmbH
Full Title: Efficacy and safety of Aethoxysklerol compared to Sodium Tetradecyl Sulfate and Isotonic Saline (placebo) for the treatment of reticular veins and spider veins including subgroup to investigate the...
Medical condition: Patients suffering from varicose veins (spider veins or reticular veins in the legs) should be treated with a sclerosing agent.
Disease: Version SOC Term Classification Code Term Level
8.1 10047001 Varicose veins LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results
EudraCT Number: 2006-005203-33 Sponsor Protocol Number: V87P3 Start Date: 2006-11-16
Sponsor Name: Novartis Vaccines and Diagnostics GmbH & Co. KG
Full Title: A Phase II, Multicenter, Exploratory Study to Evaluate Safety and Immunogenicity of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adults Unprimed and Primed with MF59-adjuvanted or Non-adjuvanted H5...
Medical condition: avian influenza
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results

EudraCT Number: 2006-004561-34 Sponsor Protocol Number: 4.2006.1285 Start Date: 2006-11-16
Sponsor Name: St. Olavs Hospital
Full Title: Tranexamic acid to elderly patients undergoing combined AVR and CABG surgery.
Medical condition: We will investigate whether tranexamic acid given as a bolus injection at the start of surgery followed by a continuous infusion during surgery reduces postoperative bleeding in patients above 70 y...
Disease: Version SOC Term Classification Code Term Level
Population Age: Elderly Gender: Male, Female
Trial protocol: NO (Ongoing)
Trial results: (No results available)
EudraCT Number: 2005-002832-93 Sponsor Protocol Number: TaxAlim01 Start Date: 2006-11-16
Sponsor Name: Städt. Krankenhaus Martha Maria Halle
Full Title: Phase I/II-Studie Kombinationschemotherapie mit Docetaxel und Pemetrexed in der 2nd line-Therapie bei Patienten mit NSCLC, Stadium IIIB und IV
Medical condition: Nichtkleinzelliges Bronchialkarzinom, Stadium IIIB und IV
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: (No results available)

EudraCT Number: 2006-004003-18 Sponsor Protocol Number: CLDT600A2406 Start Date: 2006-11-16
Sponsor Name: Novartis Pharma Services AG
Full Title: A randomized, open-label, controlled, mutli-center two-year study comparing efficacy and safety of telbivudine 600mg PO in combination with peg alpha-2a 180 µg with peg alpha-2a montherapy, and wit...
Medical condition: Treatment of naïve patients with HBeAg-positive compensated chronic hepatitis B
Disease: Version SOC Term Classification Code Term Level
8.1 10008910 Chronic hepatitis B LLT
Population Age: Adults Gender: Male, Female
Trial protocol: GB (Prematurely Ended) FR (Prematurely Ended) IT (Completed) DE (Prematurely Ended) BE (Completed) NL (Prematurely Ended)
Trial results: View results
EudraCT Number: 2006-003571-12 Sponsor Protocol Number: GLU0409 Start Date: 2006-11-15
Sponsor Name: Barts and the London NHS Trust
Full Title: Breath Methionine and Other Indices of Oxidant Stress in the Critical Care Setting. The effect of two doses of Dipeptiven given independently of parenteral nutrition.
Medical condition: 60 consecutive critically ill patients will be recruited with illnesses such as severe infection, trauma and post-surgery.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results

EudraCT Number: 2006-005635-25 Sponsor Protocol Number: 1395 Start Date: 2006-11-15
Sponsor Name: POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Full Title: Postoperative pain after cesarean section :efficacy of S-ketamine at antihyperalgesic doses.
Medical condition: Postoperative pain after cesarean section
Disease: Version SOC Term Classification Code Term Level
6.1 10006924 PT
Population Age: Adults Gender: Female
Trial protocol: IT (Completed)
Trial results: (No results available)
3